Itopride Hydrochloride (Progit®) 23031

Assessment Status Rapid Review Complete
HTA ID 23031
Drug Itopride Hydrochloride
Brand Progit®
Indication Treatment of gastrointestinal symptoms of functional dyspepsia caused by reduced gastrointestinal motility.
Assessment Process
Rapid review commissioned 06/06/2023
Rapid review completed 07/07/2023
Rapid review outcome A full HTA is not recommended. The NCPE recommends that itopride not be considered for reimbursement at the submitted price*.

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.